查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1611334

机器人药处方笺市场：按类型、应用分类 - 2025-2030 年全球预测

Robotic Pharmacy Prescription Market by Type (Centralized Dispensing Systems, Decentralized Dispensing Systems), Application (Hospital Pharmacies, Retail Pharmacies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年机器人药局处方笺市场的市场规模为1.8332亿美元，预计2024年将达到1.9681亿美元，复合年增长率为8.38%，预计到2030年将达到3.2211亿美元。

机器人药局处方笺系统代表了医疗保健领域不断发展的技术进步，旨在提高配药过程的准确性、效率和安全性。由于慢性病盛行率不断上升以及全球处方笺数量不断增加，对无错误处方笺处理的需求不断增长，对这些系统的需求源于此。应用程式主要涵盖医院药房、通讯设施和零售药房，透过自动化提供简化的操作。最终用途的范围进一步扩展到改善患者治疗效果、优化操作效率以及最大限度地减少配药过程中的人为错误。影响成长的关键因素包括技术进步、监管核准以及医疗机构对用药错误的认识提高。人工智慧和机器学习的整合来预测使用模式和管理库存为服务差异化提供了潜在的机会。然而，高昂的初始实施和维护成本、缺乏技术专业知识以及传统药局对变革的抵制可能会阻碍市场成长。监管障碍和资料隐私问题是阻碍无缝采用的额外障碍。儘管存在这些挑战，但诸如提高系统互通性、为小型药房开发客製化解决方案以及整合远端药房服务以超越传统界限等技术创新仍有考虑的空间。研究可以专注于改进使用者介面，以最大限度地提高药剂师的接受度和培训计划，以缩小技能差距，以确保无缝过渡到自动化系统。随着新参与企业提供创新且具成本效益的解决方案，而现有企业持续扩大产品系列，市场竞争将出现中度至高速成长。为了利用新的商机，相关人员正在关注与高科技公司的策略伙伴关係和合作，以确保开发可满足特定医疗保健需求的扩充性且适应性强的解决方案，机器人药局必须走在处方笺进步的最前线。

主要市场统计
基准年[2023] 1.8332 亿美元
预测年份 [2024] 1.9681亿美元
预测年份 [2030] 3.2211亿美元
复合年增长率（%） 8.38%

市场动态：快速发展的机器人药局处方笺市场的关键市场洞察

供需的动态交互作用正在改变机器人药局处方笺市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 扩大全球医疗保健服务
    • 机器人药局的接受度提高，时间支出减少
    • 处方系统效率和有效性提高带来的潜在需求
  • 市场限制因素
    • 机器人和备件相关的高成本
  • 市场机会
    • 机器人设计和功能的新增强
    • 不断发展的医疗保健安全和隐私保证
  • 市场挑战
    • 对机器人系统定期故障的担忧

波特五力：驾驭机器人药局处方笺市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解机器人药局处方笺市场的外部影响

外部宏观环境因素在塑造机器人药局处方笺市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解机器人药处方笺市场竞争状况

机器人药局处方笺市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵机器人药局处方笺市场供应商绩效评估

FPNV 定位矩阵是评估机器人药局处方笺市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划机器人药局处方笺市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对机器人药局处方笺市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 医疗保健服务正在全球范围内急剧扩张
      • 扩大机器人药局的接受度并减少时间消耗
      • 提高处方系统效率和有效性的潜在需求
    • 抑制因素
      • 与机器人和备件相关的高成本
    • 机会
      • 机器人设计和功能的新增强
      • 建立医疗保健领域的安全和隐私保证
    • 任务
      • 对机器人系统定期故障的担忧
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章机器人药局处方笺市场：按类型

  • 集中分配系统
  • 去中心化分配系统

第七章 机器人药局处方笺市场：依应用分类

  • 医院药房
  • 零售药房

第八章 美洲机器人药局处方笺市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太机器人药局处方笺市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲机器人药局处方笺市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbacusRx Pharmacy Systems Inc.
  • Accu-Chart Plus Healthcare Systems
  • ARxIUM Inc.
  • Becton, Dickinson and Company
  • Capsa Solutions, LLC
  • Centred Solutions UK
  • Gebr. Willach GmbH
  • McKesson Corporation
  • Noritsu America Corporation
  • Omnicell, Inc.
  • Oracle Corporation
  • RxSafe, LLC
  • Scriptpro LLC
  • Tension Packaging & Automation
  • Yuyama Co., Ltd.
Product Code: MRR-2D64BA93A4E3

The Robotic Pharmacy Prescription Market was valued at USD 183.32 million in 2023, expected to reach USD 196.81 million in 2024, and is projected to grow at a CAGR of 8.38%, to USD 322.11 million by 2030.

Robotic pharmacy prescription systems represent an evolving technological advancement within the healthcare sector, aimed at enhancing the precision, efficiency, and safety of medication dispensing processes. The necessity for these systems stems from the rising demand for error-free prescription fulfillment, driven by the increased prevalence of chronic diseases and the growing number of prescriptions being filled globally. Applications primarily span hospital pharmacies, mail-order facilities, and retail pharmacies, offering streamlined operations through automation. End-use scope further extends to improving patient outcomes, optimizing workforce efficiency, and minimizing human error during medication dispensing. Key factors influencing growth include technological advancements, regulatory endorsements, and heightened awareness about medication errors among healthcare institutions. The integration of artificial intelligence and machine learning to predict usage patterns and manage inventory offers potential opportunities for service differentiation. However, market growth may be hampered by high initial installation and maintenance costs, lack of technical expertise, and resistance to change among traditional pharmacy setups. Regulatory hurdles and data privacy concerns are additional hurdles that could impede seamless adoption. Despite these challenges, innovation areas ripe for exploration include enhancing system interoperability, developing bespoke solutions for small-scale pharmacies, and integrating telepharmacy services to extend reach beyond conventional boundaries. Research can pivot towards refining user interfaces to maximize pharmacist acceptance and training programs to bridge skill gaps, ensuring a seamless transition to automated systems. The market is poised for growth with a moderate to high competitive intensity, as new entrants provide innovative, cost-effective solutions while established players continue to enhance their product portfolios. To leverage emerging opportunities, stakeholders need to focus on strategic partnerships and collaborations with tech firms, ensuring the development of scalable and adaptable solutions that address specific healthcare needs, thus positioning themselves at the forefront of robotic pharmacy prescription advancements.

KEY MARKET STATISTICS
Base Year [2023] USD 183.32 million
Estimated Year [2024] USD 196.81 million
Forecast Year [2030] USD 322.11 million
CAGR (%) 8.38%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Robotic Pharmacy Prescription Market

The Robotic Pharmacy Prescription Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing tremendous expansion of healthcare services worldwide
    • Increasing acceptance for robotic pharmacy coupled with reducing time expenditure
    • Potential demand attributed to increasing efficiency and effectiveness of prescription system
  • Market Restraints
    • High cost associated with robotics and spare parts
  • Market Opportunities
    • Emerging enhancements in robotics design and functionalities
    • Developing assurance regarding safety and privacy in healthcare
  • Market Challenges
    • Concerns regarding regular breakdown of robotic systems

Porter's Five Forces: A Strategic Tool for Navigating the Robotic Pharmacy Prescription Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Robotic Pharmacy Prescription Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Robotic Pharmacy Prescription Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Robotic Pharmacy Prescription Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Robotic Pharmacy Prescription Market

A detailed market share analysis in the Robotic Pharmacy Prescription Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Robotic Pharmacy Prescription Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Robotic Pharmacy Prescription Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Robotic Pharmacy Prescription Market

A strategic analysis of the Robotic Pharmacy Prescription Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Robotic Pharmacy Prescription Market, highlighting leading vendors and their innovative profiles. These include AbacusRx Pharmacy Systems Inc., Accu-Chart Plus Healthcare Systems, ARxIUM Inc., Becton, Dickinson and Company, Capsa Solutions, LLC, Centred Solutions UK, Gebr. Willach GmbH, McKesson Corporation, Noritsu America Corporation, Omnicell, Inc., Oracle Corporation, RxSafe, LLC, Scriptpro LLC, Tension Packaging & Automation, and Yuyama Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Robotic Pharmacy Prescription Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Centralized Dispensing Systems and Decentralized Dispensing Systems.
  • Based on Application, market is studied across Hospital Pharmacies and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing tremendous expansion of healthcare services worldwide
      • 5.1.1.2. Increasing acceptance for robotic pharmacy coupled with reducing time expenditure
      • 5.1.1.3. Potential demand attributed to increasing efficiency and effectiveness of prescription system
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with robotics and spare parts
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging enhancements in robotics design and functionalities
      • 5.1.3.2. Developing assurance regarding safety and privacy in healthcare
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding regular breakdown of robotic systems
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Robotic Pharmacy Prescription Market, by Type

  • 6.1. Introduction
  • 6.2. Centralized Dispensing Systems
  • 6.3. Decentralized Dispensing Systems

7. Robotic Pharmacy Prescription Market, by Application

  • 7.1. Introduction
  • 7.2. Hospital Pharmacies
  • 7.3. Retail Pharmacies

8. Americas Robotic Pharmacy Prescription Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Robotic Pharmacy Prescription Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Robotic Pharmacy Prescription Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbacusRx Pharmacy Systems Inc.
  • 2. Accu-Chart Plus Healthcare Systems
  • 3. ARxIUM Inc.
  • 4. Becton, Dickinson and Company
  • 5. Capsa Solutions, LLC
  • 6. Centred Solutions UK
  • 7. Gebr. Willach GmbH
  • 8. McKesson Corporation
  • 9. Noritsu America Corporation
  • 10. Omnicell, Inc.
  • 11. Oracle Corporation
  • 12. RxSafe, LLC
  • 13. Scriptpro LLC
  • 14. Tension Packaging & Automation
  • 15. Yuyama Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. ROBOTIC PHARMACY PRESCRIPTION MARKET RESEARCH PROCESS
  • FIGURE 2. ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ROBOTIC PHARMACY PRESCRIPTION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ROBOTIC PHARMACY PRESCRIPTION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ROBOTIC PHARMACY PRESCRIPTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ROBOTIC PHARMACY PRESCRIPTION MARKET DYNAMICS
  • TABLE 7. GLOBAL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY CENTRALIZED DISPENSING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY DECENTRALIZED DISPENSING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM ROBOTIC PHARMACY PRESCRIPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ROBOTIC PHARMACY PRESCRIPTION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. ROBOTIC PHARMACY PRESCRIPTION MARKET, FPNV POSITIONING MATRIX, 2023